Ten questions that separate a transparent compounded tirzepatide provider from a careless one. Print it, then run every provider through it.
Work through a transparency checklist: full pricing disclosed, whether price rises by dose, what's included (labs, visits, shipping), named 503A/503B pharmacy, clear cancellation terms, visible not-FDA-approved disclaimer, ongoing access, and medically reviewed claims.
Opacity about the pharmacy — an unnamed pharmacy, no 503A/503B status, and no certificate of analysis. Because compounded tirzepatide isn't FDA-approved, pharmacy transparency is the key quality signal.